NZ217239A - Liposomes containing phospholipid compounds - Google Patents
Liposomes containing phospholipid compoundsInfo
- Publication number
- NZ217239A NZ217239A NZ217239A NZ21723986A NZ217239A NZ 217239 A NZ217239 A NZ 217239A NZ 217239 A NZ217239 A NZ 217239A NZ 21723986 A NZ21723986 A NZ 21723986A NZ 217239 A NZ217239 A NZ 217239A
- Authority
- NZ
- New Zealand
- Prior art keywords
- appropriate
- pharmaceutically acceptable
- phospholipid
- alkylene
- atoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The compositions consist of a) a phospholipid of the formula <IMAGE> in which m is two or three, R1 and R2 are, independently of one another, alkyl, alkenyl or acyl each with 10 to 20 C atoms, and X is a direct bond, C1-C4-alkylene, C2-C4-alkenylene or C1-C4-alkylene or C2-C4-alkenylene substituted by hydroxyl, or a pharmaceutically acceptable salt thereof, b) a phospholipid of the formula <IMAGE> in which R3 and R4 are the acyl group of a saturated or unsaturated carboxylic acid with 10 to 20 C atoms and 1 to 2 double bonds, c) a compound or a mixture of compounds with pharmacological properties and, where appropriate, d) a lipid from the group comprising phosphatidylcholines, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, cardiolipin and cholesterol and, where appropriate, a pharmaceutically acceptable carrier solution which is buffered to pH 7.0 to 7.8 and, where appropriate, pharmaceutically acceptable auxiliaries. The compositions can be used in the form of liposomes as administration systems, for example for cancer chemotherapy.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76662585A | 1985-08-19 | 1985-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ217239A true NZ217239A (en) | 1989-09-27 |
Family
ID=25077017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ217239A NZ217239A (en) | 1985-08-19 | 1986-08-18 | Liposomes containing phospholipid compounds |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0213523B1 (en) |
| JP (1) | JPS6296431A (en) |
| KR (1) | KR870001838A (en) |
| AT (1) | ATE59002T1 (en) |
| AU (1) | AU591162B2 (en) |
| CA (1) | CA1273575A (en) |
| DD (1) | DD248736A5 (en) |
| DE (1) | DE3676133D1 (en) |
| DK (1) | DK165314C (en) |
| ES (1) | ES2001099A6 (en) |
| FI (1) | FI863311A (en) |
| GR (1) | GR862144B (en) |
| HU (1) | HU206045B (en) |
| NO (1) | NO171886C (en) |
| NZ (1) | NZ217239A (en) |
| PH (1) | PH26160A (en) |
| PT (1) | PT83204B (en) |
| ZA (1) | ZA866200B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT85537B (en) * | 1986-08-18 | 1990-06-29 | Univ Texas | METHOD FOR PREPARING A PHARMACEUTICAL ADMINISTRATION SYSTEM CONTAINING PEPTIDES PRESENTING CHIMIOTAXIA |
| DK86988A (en) * | 1987-02-25 | 1988-08-26 | Takeda Chemical Industries Ltd | LIPOSOM PREPARATION AND APPLICATION THEREOF |
| AU7496991A (en) * | 1990-03-20 | 1991-10-21 | Otsuka Pharmaceutical Co., Ltd. | Liposome preparation |
| EP1118326A3 (en) * | 1993-05-21 | 2002-07-31 | The Liposome Company, Inc. | Reduction of liposome-induced adverse physiological reactions |
| KR100381449B1 (en) * | 1994-10-14 | 2003-07-18 | 더 리포좀 컴퍼니, 인코퍼레이티드 | Application of ether lipid liposomal enzymes to pharmaceuticals |
| US7306784B2 (en) | 1998-06-20 | 2007-12-11 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US6589503B1 (en) | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US8038984B2 (en) | 1998-06-20 | 2011-10-18 | Washington University | Membrane-permeant peptide complexes for treatment of sepsis |
| US7803351B2 (en) | 2004-08-20 | 2010-09-28 | Washington University | Blood brain barrier permeation peptides |
| JP2006248978A (en) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
| EP3676296A1 (en) | 2017-08-30 | 2020-07-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3218027A1 (en) * | 1982-05-13 | 1983-11-17 | A. Nattermann & Cie GmbH, 5000 Köln | PHOSPHOLIPID SOLUTIONS |
-
1986
- 1986-07-18 PH PH34151A patent/PH26160A/en unknown
- 1986-08-14 PT PT83204A patent/PT83204B/en not_active IP Right Cessation
- 1986-08-15 FI FI863311A patent/FI863311A/en not_active Application Discontinuation
- 1986-08-15 CA CA000516015A patent/CA1273575A/en not_active Expired - Fee Related
- 1986-08-18 KR KR1019860006783A patent/KR870001838A/en not_active Application Discontinuation
- 1986-08-18 DK DK392786A patent/DK165314C/en not_active IP Right Cessation
- 1986-08-18 DD DD86293707A patent/DD248736A5/en not_active IP Right Cessation
- 1986-08-18 ZA ZA866200A patent/ZA866200B/en unknown
- 1986-08-18 AU AU61556/86A patent/AU591162B2/en not_active Ceased
- 1986-08-18 JP JP61191795A patent/JPS6296431A/en active Pending
- 1986-08-18 AT AT86111368T patent/ATE59002T1/en not_active IP Right Cessation
- 1986-08-18 ES ES8601163A patent/ES2001099A6/en not_active Expired
- 1986-08-18 HU HU863618A patent/HU206045B/en not_active IP Right Cessation
- 1986-08-18 NO NO863315A patent/NO171886C/en unknown
- 1986-08-18 GR GR862144A patent/GR862144B/en unknown
- 1986-08-18 DE DE8686111368T patent/DE3676133D1/en not_active Expired - Fee Related
- 1986-08-18 EP EP86111368A patent/EP0213523B1/en not_active Expired - Lifetime
- 1986-08-18 NZ NZ217239A patent/NZ217239A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI863311A0 (en) | 1986-08-15 |
| KR870001838A (en) | 1987-03-28 |
| DK392786D0 (en) | 1986-08-18 |
| AU591162B2 (en) | 1989-11-30 |
| NO171886C (en) | 1993-05-19 |
| DK165314C (en) | 1993-03-29 |
| FI863311A (en) | 1987-02-20 |
| NO171886B (en) | 1993-02-08 |
| AU6155686A (en) | 1987-02-26 |
| DD248736A5 (en) | 1987-08-19 |
| PT83204B (en) | 1989-03-30 |
| PT83204A (en) | 1986-09-01 |
| EP0213523A2 (en) | 1987-03-11 |
| NO863315D0 (en) | 1986-08-18 |
| EP0213523A3 (en) | 1987-10-14 |
| ES2001099A6 (en) | 1988-04-16 |
| HU206045B (en) | 1992-08-28 |
| DE3676133D1 (en) | 1991-01-24 |
| CA1273575A (en) | 1990-09-04 |
| JPS6296431A (en) | 1987-05-02 |
| DK392786A (en) | 1987-02-20 |
| EP0213523B1 (en) | 1990-12-12 |
| NO863315L (en) | 1987-02-20 |
| DK165314B (en) | 1992-11-09 |
| ATE59002T1 (en) | 1990-12-15 |
| ZA866200B (en) | 1987-03-25 |
| PH26160A (en) | 1992-03-18 |
| HUT41634A (en) | 1987-05-28 |
| GR862144B (en) | 1986-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ217239A (en) | Liposomes containing phospholipid compounds | |
| ES8707178A1 (en) | Process for the preparation of specific enantiomer pairs of permethrin alpha-cyano-3-phenoxy-4-fluorobenzyl ester. | |
| EP0237051A3 (en) | Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same | |
| FI904850A0 (en) | Process for the preparation of novel therapeutically useful 24-homo-vitamin D derivatives | |
| HUT35957A (en) | Process for producing phosholipide compositions and pharmaceutical compositions containing them as active agents | |
| EP0507337A3 (en) | Novel erucyl, brassidyl and nervonyl derivatives | |
| AU5791190A (en) | New peptide derivatives, process for preparing them and pharmaceutical compositions containing them | |
| IL87254A (en) | Stable oxapenem- 3-carboxylic acids, their preparation and pharmaceutical compositions containing them | |
| AU586086B2 (en) | 1,5-benzothiazepine derivatives, their preparation and compositions containing them | |
| GR3002567T3 (en) | Substituted 3-aminosydnonimines, process for their preparation and their use | |
| ES8505806A1 (en) | Alkylsulfonium salts of N-phosphonomethylglycine. | |
| AU586477B2 (en) | Hexenoic acids | |
| ES8704970A1 (en) | Process for the preparation of corticosteroid-21-phosphoric acids and their salts, and the triesters of certicusteroid-21-phosphoric acid. | |
| KR880012544A (en) | Benzenesulfonamide Derivatives and Preparation Methods Thereof | |
| PT86422A (en) | PROCESS FOR THE PREPARATION OF DIBENZO] BE-OXEPINE-ACETIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |